Apex AI is an artificial intelligence-driven healthcare startup focused on revolutionizing early detection and predictive diagnostics for gastrointestinal cancers, specifically stomach and colorectal cancer. Apex AI leverages advanced machine learning algorithms and extensive datasets comprising over 1 million endoscopic images to significantly enhance diagnostic accuracy, achieving 95%+ accuracy for stomach cancer and 98%+ for colorectal cancer. The platform provides real-time AI-powered endoscopic analysis, continuous disease monitoring, and precise risk assessment, helping clinicians identify early-stage cancers and precancerous lesions effectively. Apex AI aims to bridge the existing diagnostic gap caused by human error, asymptomatic disease progression, and limited early-stage detection capabilities, ultimately improving patient survival rates and clinical outcomes worldwide.
Apex AI Price Analysis
As of June 25 2025 Apex AI has a marketcap of $1.8M.
This is {{percentagefromath}} from its all time high of $0.00611562.
In terms of its tokenomics, there's a total supply of 998M with 100% currently outstanding.
Keep in mind Apex AI has a fully diluted value of $1.8M which many investors might interpret as overvalued.
Of course, don’t trust price predictions alone, always check the Coinrotator token screener to follow the trending market.
Summarized in part by ChatGPT 4 and Claude
